ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs MXN
17.73555
0.19%
Brent Oil
84.34
-0.30%
Bitcoin
64,729.76
6.50%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Acceleron Pharma Inc (XLRN)

  7. Acceleron Pharma Inc (XLRN) Noticias

XLRN

Acceleron Pharma (XLRN)

Acceleron Pharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XLRN
FechaHoraFuenteTítuloSímboloCompañía
21/05/201410:00Business WireAcceleron Announces New Interim Phase 2 Data on Sotatercept & ACE-536 to be Reported at Three Oral Presentations at the 19th ...NASDAQ:XLRNAcceleron Pharma Inc
15/05/201408:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XLRNAcceleron Pharma Inc
15/05/201406:38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XLRNAcceleron Pharma Inc
15/05/201406:30Business WireAcceleron Pharma Reports First Quarter 2014 Financial ResultsNASDAQ:XLRNAcceleron Pharma Inc
14/05/201416:00Business WireAcceleron to Report New Encouraging Interim Clinical Data from Phase 2 Trial of Dalantercept in Renal Cell Carcinoma at the 5...NASDAQ:XLRNAcceleron Pharma Inc
13/05/201416:29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XLRNAcceleron Pharma Inc
12/05/201410:26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XLRNAcceleron Pharma Inc
12/05/201406:00Business WireAcceleron to Present at 2014 UBS Global Healthcare ConferenceNASDAQ:XLRNAcceleron Pharma Inc
08/05/201406:00Business WireAcceleron Pharma to Host First Quarter 2014 Financial Results Conference Call and Webcast on May 15, 2014NASDAQ:XLRNAcceleron Pharma Inc
07/05/201416:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
02/05/201415:24Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XLRNAcceleron Pharma Inc
30/04/201416:25Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:XLRNAcceleron Pharma Inc
23/04/201415:30Business WireAcceleron & Celgene Announce Interim Clinical Data for Sotatercept Demonstrating Dose Dependent Increases in Hemoglobin in Pa...NASDAQ:XLRNAcceleron Pharma Inc
11/04/201407:00PR Newswire (US)FDA Recommendations, Study Publications, Recognitions, Agreements, and Acquisitions - Analyst Notes on MannKind, Acceleron, S...NASDAQ:XLRNAcceleron Pharma Inc
02/04/201409:54Dow Jones NewsCelgene Agrees to Acquire 1.1 Million Acceleron Pharma SharesNASDAQ:XLRNAcceleron Pharma Inc
24/03/201406:30Business WireAcceleron, Celgene & Collaborators Announce Two Publications in Nature Medicine Describing Sotatercept & ACE-536 Therapeutic ...NASDAQ:XLRNAcceleron Pharma Inc
21/03/201407:00PR Newswire (US)Earnings Release and Presentation Schedules, Nominations, and Financial Results - Analyst Notes on Five Prime Therapeutics, A...NASDAQ:XLRNAcceleron Pharma Inc
20/03/201406:30Business WireAcceleron to Present at the 21st Annual Future Leaders in the Biotech Industry ConferenceNASDAQ:XLRNAcceleron Pharma Inc
17/03/201416:27Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XLRNAcceleron Pharma Inc
17/03/201415:30Business WireAcceleron & Celgene Announce Interim Clinical Data for Sotatercept in Patients with End Stage Renal Disease on Hemodialysis a...NASDAQ:XLRNAcceleron Pharma Inc
07/03/201405:19PR Newswire (US)Financial Results Releases, Clinical Study Updates, Stock Summaries, and Strategic Agreements - Analyst Notes on Insmed, Medt...NASDAQ:XLRNAcceleron Pharma Inc
27/02/201406:00Business WireAcceleron to Present at Cowen and Company 34th Annual Health Care ConferenceNASDAQ:XLRNAcceleron Pharma Inc
26/02/201406:00Business WireAcceleron Pharma Reports Fourth Quarter and Year Ended 2013 Financial ResultsNASDAQ:XLRNAcceleron Pharma Inc
19/02/201406:00Business WireAcceleron Pharma to Host Fourth Quarter and Year Ended 2013 Financial Results Conference Call and Webcast on February 26, 2014NASDAQ:XLRNAcceleron Pharma Inc
14/02/201415:35Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XLRNAcceleron Pharma Inc
14/02/201412:47Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:XLRNAcceleron Pharma Inc
05/02/201406:00Business WireAcceleron to Present at 2014 Leerink Global Healthcare ConferenceNASDAQ:XLRNAcceleron Pharma Inc
28/01/201415:30Business WireAcceleron Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:XLRNAcceleron Pharma Inc
22/01/201421:30Business WireAcceleron Announces Pricing of Public Offering of Common StockNASDAQ:XLRNAcceleron Pharma Inc
21/01/201405:30Business WireAcceleron Commences Proposed Public Offering of Common StockNASDAQ:XLRNAcceleron Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:XLRN

Su Consulta Reciente

USOTC
HRGN
Harvard Apparatus Regene... (QB)
BIT
P21RY3
NLBNPIT21RY3 20991231 22...
BIT
P1FND7
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados